Heart Failure News and Research

RSS
Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.
Highlights of Cell Therapeutics' pixantrone study to be presented at the Lymphoma and Myeloma Conference

Highlights of Cell Therapeutics' pixantrone study to be presented at the Lymphoma and Myeloma Conference

Study explores aldosterone antagonist usage among US patients hospitalised with heart failure

Study explores aldosterone antagonist usage among US patients hospitalised with heart failure

People in developing countries spend 90% of all medical expenditures for diabetes care

People in developing countries spend 90% of all medical expenditures for diabetes care

Millennium commences Vc-R-CHOP Phase II trial for diffuse large B-cell lymphoma

Millennium commences Vc-R-CHOP Phase II trial for diffuse large B-cell lymphoma

Lake Health opens TriPoint Medical Center in Concord Township

Lake Health opens TriPoint Medical Center in Concord Township

Study of aldosterone antagonist usage among patients hospitalised with heart failure published

Study of aldosterone antagonist usage among patients hospitalised with heart failure published

APP Pharmaceuticals to launch Chlorothiazide Sodium for Injection

APP Pharmaceuticals to launch Chlorothiazide Sodium for Injection

St. Jude Medical's quadripolar pacing system receives European CE Mark approval

St. Jude Medical's quadripolar pacing system receives European CE Mark approval

Eclipsys supports healthcare providers to meet the goal of ARRA

Eclipsys supports healthcare providers to meet the goal of ARRA

Two high blood pressure medicines effective in treating stable ischemic heart disease

Two high blood pressure medicines effective in treating stable ischemic heart disease

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

SIMPONI treatment results in greater inhibition of structural damage in arthritis patients

SIMPONI treatment results in greater inhibition of structural damage in arthritis patients

Physicians say thyroid surgery safe for older people

Physicians say thyroid surgery safe for older people

Cumberland Pharmaceuticals publishes data on its Phase III intravenous ibuprofen study

Cumberland Pharmaceuticals publishes data on its Phase III intravenous ibuprofen study

Menarini granted exclusive European licence rights to Ipsen's Adenuric

Menarini granted exclusive European licence rights to Ipsen's Adenuric

Third-quarter financial results of Boston Scientific announced

Third-quarter financial results of Boston Scientific announced

UCB reports on the outcome of Cimzia and MTX treatment for rheumatoid arthritis

UCB reports on the outcome of Cimzia and MTX treatment for rheumatoid arthritis

Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its Micardis Tablets 80 mg

Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its Micardis Tablets 80 mg

New data on Phase 3 SIMPONI clinical trials for rheumatoid arthritis

New data on Phase 3 SIMPONI clinical trials for rheumatoid arthritis

New mathematical model for rapid and accurate diagnoses of AHF

New mathematical model for rapid and accurate diagnoses of AHF

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.